Yes, it now has approval from NICE. No prescribing criteria yet to my knowledge other than it’s for active RR. I know someone who did the trial. She’s had no relapses since her first lot in December 2009. She was previously relapsing every three months. I have an appointment next month at Addenbrookes next month and I’m going to be asking for it. I’ve had five relapses in the last eighteen months and I’m currently not on a DMD after ten years of being on Rebif (for nine) and Gilenya (for one) I’m struggling badly but I’m prepared to wait as I firmly believe it can be the game changer I so desperately need. Interestingly, when the lady I know did the trial, it was £1,100 plus inpatient costs per infusion - apparently it’s now £56,000 per infusion! I’m gobsmacked it was agreed by NICE so quickly but I’m guessing it’s results have been so good, they figure it will save money in the long run.